A Powerful Test For Better Management and Monitoring of Cancer Treatments
What
Real time monitoring of cancer burden, molecular dynamics, treatment response and emerging treatment resistance.
For Whom
For all patients who have either been diagnosed with cancer or are receiving anticancer treatments or are in remission*.
*Recurrence Monitoring only
How
Circulating tumor components (CTCs*, DNA and RNA) are isolated from a blood sample and analyzed to determine tumor molecular dynamics and characteristics. (*Recurrence Monitoring only).
Why
Cancertrack™ provides a detailed insight into the burden of cancer (including signs of recurrence), treatment response and potential innate / emergent drug resistance mechanisms.
Advantages
- Non-invasive blood test is safe, accurate, simple, and cost-effective,
- Not dependent on the availability of tissue,
- Provides more information than standard tissue biopsy and HPE at diagnosis,
- Extensive coverage of NCCN recommended biomarkers,
- Unencumbered by tumor heterogeneity,
- Provides relevant real-time tumor status,
- Can be easily performed as often as required,
- Ultra-sensitive, precise and accurate.
Explore
Explore
A Simple Blood Test To Detect Cancer Early,
So That It Could Be Cured.
Contact Us
10 Medawar Road,
The Surrey Research Park, Guildford,
Surrey, GU2 7AE, United Kingdom
Lessingweg1,
Bayreuth 95447,
Germany
Maharashtra – 422010.
India